Similar articles

• Serum transaminase in pulmonary disease and multiple infarctions.

  WALSH JR, HUMOLLER FL, GILLICK FG. WALSH JR, et al. Ann Intern Med. 1957 Jun;46(6):1105-12. doi: 10.7326/0003-4819-46-6-1105. Ann Intern Med. 1957. PMID: 13435659 No abstract available.
• [The differential diagnosis between myocardial- and lung infarction by the determination of serum enzyme activity].

  KLAUS D, ZEH E. KLAUS D, et al. Dtsch Med Wochenschr. 1961 Mar 17;86:480-3. doi: 10.1055/s-0028-1112810. Dtsch Med Wochenschr. 1961. PMID: 13756572 German. No abstract available.
• Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction.

  NYDICK I, RUEGSEGGER P, WROBLEWSKI F, LADUE JS. NYDICK I, et al. Circulation. 1957 Mar;15(3):324-34. doi: 10.1161/01.cir.15.3.324. Circulation. 1957. PMID: 13404705 No abstract available.
• Serum transaminase levels in experimental pulmonary infarction.

  AGRESS CM, GLASSNER HF, JACOBS HI. AGRESS CM, et al. Circ Res. 1956 Mar;4(2):220-2. doi: 10.1161/01.res.4.2.220. Circ Res. 1956. PMID: 13293824 No abstract available.
• Serum transaminase activity (glutamic-oxalacetic and glutamic-pyruvic transaminases) in destructive pulmonary diseases.

  BERTOLINI AM, GUARDAMAGNA C, MASSARI N, QUARTO DI PALO F. BERTOLINI AM, et al. Acta Vitaminol. 1958 Aug;12(4):159-61. Acta Vitaminol. 1958. PMID: 13605960 English, Italian. No abstract available.